Ann: LCT Strategy Update, page-41

Lets hope for something spectacular, solid positive data that demonstrates LCT Primary End Point Claims...Going to need to be far better than Reasonable Whytee... Over $65m and 12 years ,, my expectations are obviously higher ,, I'm expecting it to be a company Breaker or Maker.... LCT have not Commercialised any Technology,, the Biotech sector has changed ,,even the small Biotechs are focusing in on revenue from products even if it is in the low Millions,,it's income and that's scale able , LCT is looking like it was a lifestyle company for Management,, the only thing I see that will save them and the company is positive results...
Oh and Monitoring Trial Patients till May 2019 ???? if these results aren't positive then it's over "A treatment for Parkinson's that costs $100k and you have to wait, 1,2,3, years and it might work".. No positive results No Company